Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy - Diksha Manhas; Shipra Bhatt; Garima Rai; Vinay Kumar; Sahil Bharti; Sumit Dhiman; Shreyans K. Jain; Deepak K. Sharma; Probir Kumar Ojha; Sumit G. Gandhi; Anindya Goswami; Utpal Nandi (Chemico-Biological Interactions, 2023)